Effector CD8+ T cells are a crucial T cell population to eliminate malignant cells in cancer.44 Thus, we next evaluated the role of ADAM17 in regulating the anti-tumor activity of CD8+ T cells. This evidence concerns the gene ADAM17 and neoplasm.